TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 DBMR VENDOR SHARE ANALYSIS
2.8 MULTIVARIATE MODELING
2.9 PRODUCTS LIFELINE CURVE
2.10 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISE IN THE AGEING POPULATION AND AN INCREASE IN RATE OF CHRONIC DISEASES
3.1.2 ADVANCED DEVELOPMENT IN MULTI-PARAMETER MONITORS
3.1.3 INCREASE IN NUMBER OF HEALTH CARE FACILITIES ACROSS THE GLOBE
3.1.4 RAPID ADOPTION OF DIGITIZATION IN HEALTHCARE INDUSTRY
3.2 RESTRAINTS
3.2.1 HIGH COST OF EQUIPMENT
3.2.2 USAGE OF REFURBISHED PATIENT MONITORS
3.3 OPPORTUNITY
3.3.1 RISING DEMAND FOR HOME-USE AND REMOTE PATIENT MONITORING DEVICES
3.3.2 DEVELOPMENT OF WIRELESS PATIENT MONITORS WITH NEW SENSOR TECHNOLOGY
3.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
3.3.4 RISING HEALTHCARE EXPENDITURE
?
3.4 CHALLENGES
3.4.1 STRINGENT REGULATORY POLICIES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 VENTILATORS
6.2.1 INVASIVE
6.2.2 NON-INVASIVE
6.2.3 PORTABLE
6.2.4 STANDALONE
6.3 PATIENT MONITORS
6.3.1 HEMODYNAMIC MONITORING
6.3.2 INTRACRANIAL PRESSURE MONITOR DEVICES
6.3.3 NEUROMONITORING DEVICES
6.3.4 CARDIAC MONITORING DEVICES
6.3.5 RESPIRATORY MONITORING DEVICES
6.3.6 FETAL AND NEONATAL MONITORING
6.3.7 OTHERS
6.3.8 PORTABLE
6.3.9 STANDALONE
6.3.10 INVASIVE
6.3.11 NON-INVASIVE
6.4 INFUSION PUMP
6.4.1 VOLUMETRIC INFUSION PUMP SYSTEMS
6.4.2 SYRINGE INFUSION PUMP SYSTEMS
6.4.3 AMBULATORY INFUSION PUMP SYSTEM
6.4.4 ENTERAL INFUSION PUMP SYSTEM
6.4.5 INSULIN INFUSION PUMP SYSTEM
6.4.6 IMPLANTABLE INFUSION PUMP SYSTEM
6.4.7 PATIENT-CONTROLLED ANALGESIC
6.4.8 OTHERS
6.5 SLEEP APNEA DEVICES
6.5.1 CPAP/APAP SYSYTEM
6.5.2 BPAP SYSYTEM
?
6.6 BLOOD WARMER
6.6.1 SURFACE WARMING SYSTEM
6.6.2 INTRAVENOUS WARMING SYSTEM
6.6.3 PATIENT WARMING ACCESSORIES
6.7 DEFIBRILLATOR
6.7.1 EXTERNAL DEFIBRILLATORS
6.7.2 IMPLANTABLE DEFIBRILLATORS
6.7.3 PORTABILITY
6.7.3.1 SEMI-AUTOMATED
6.7.3.2 FULLY AUTOMATED
6.7.3.3 MANUAL
6.7.4 ANESTHESIA MACHINE
6.7.4.1 STAND ALONE ANESTHESIA MACHINES
6.7.4.2 PORTABLE ANESTHESIA MACHINES
6.7.4.3 ANAESTHESIA WORKSTATIONS
7 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY TYPE OF MONITORING
7.1 OVERVIEW
7.2 HEMODYNAMIC MONITORING
7.3 VITAL SIGNS MONITORING
7.4 NEUROLOGIC MONITORING
7.5 BRAIN FUNCTION MONITORING
8 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY PATIENT
8.1 OVERVIEW
8.2 PEDIATRIC AND NEONATES
8.3 ADULT
8.4 GERIATRIC
9 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DEEP VEIN THROMBOSIS
9.3 PULMONARY EMBOLISM
9.4 ACUTE CORONARY SYNDROME
9.5 ATRIAL FIBRILLATION
9.6 HEMODIALYSIS
9.7 CORONARY ANGIOPLASTY
9.8 SURGERIES
10 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY END-USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 AMBULATORY SURGICAL CENTRES
10.4 CLINICS
10.5 HOMECARE SETTINGS
10.6 TRAUMA CENTER
10.7 OTHERS
11 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDERS
11.3 DISTRIBUTOR & TENDER
12 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, BY GEOGRAPHY
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA CRITICAL CARE EQUIPMENT MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 COMPANY PROFILES
14.1 KONINKLIJKE PHILIPS N.V.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 GENERAL ELECTRIC
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENT
14.3 MEDTRONIC
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENT
14.4 B. BRAUN MELSUNGEN AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 DRaGERWERK AG & CO. KGAA
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.6 EDWARDS LIFESCIENCES CORPORATION
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENT
14.7 FRESENIUS MEDICAL CARE AG & CO. KGAA
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 GETINGE AB
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 HEYER MEDICAL AG
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.10 INTEGRA LIFESCIENCES CORPORATION
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCT PORTFOLIO
14.10.4 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS